OA12286A - 2-Aminothiazoline derivatives and their use as no-synthase inhibitors. - Google Patents
2-Aminothiazoline derivatives and their use as no-synthase inhibitors. Download PDFInfo
- Publication number
- OA12286A OA12286A OA1200200372A OA1200200372A OA12286A OA 12286 A OA12286 A OA 12286A OA 1200200372 A OA1200200372 A OA 1200200372A OA 1200200372 A OA1200200372 A OA 1200200372A OA 12286 A OA12286 A OA 12286A
- Authority
- OA
- OAPI
- Prior art keywords
- dihydro
- thiazol
- ylamine
- temperature
- radical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0007397A FR2810037B1 (fr) | 2000-06-09 | 2000-06-09 | Utilisation de derives de 2-aminothiazoline comme inhibiteurs de no-synthase inductible |
Publications (1)
Publication Number | Publication Date |
---|---|
OA12286A true OA12286A (en) | 2006-05-12 |
Family
ID=8851134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA1200200372A OA12286A (en) | 2000-06-09 | 2001-06-07 | 2-Aminothiazoline derivatives and their use as no-synthase inhibitors. |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP1299365B1 (da) |
JP (1) | JP4238026B2 (da) |
KR (1) | KR20030025931A (da) |
CN (1) | CN1202096C (da) |
AP (1) | AP2002002708A0 (da) |
AR (1) | AR029937A1 (da) |
AT (1) | ATE305460T1 (da) |
AU (1) | AU2001266124A1 (da) |
BR (1) | BR0111986A (da) |
CA (1) | CA2411760C (da) |
DE (1) | DE60113689T2 (da) |
DK (1) | DK1299365T3 (da) |
DZ (1) | DZ3367A1 (da) |
EA (1) | EA200300010A1 (da) |
EC (1) | ECSP024375A (da) |
ES (1) | ES2248347T3 (da) |
FR (1) | FR2810037B1 (da) |
HK (1) | HK1057900A1 (da) |
HR (1) | HRP20020970A2 (da) |
HU (1) | HUP0301000A2 (da) |
IL (1) | IL153328A0 (da) |
MA (1) | MA25814A1 (da) |
MX (1) | MXPA02012071A (da) |
NO (1) | NO20025884L (da) |
NZ (1) | NZ522968A (da) |
OA (1) | OA12286A (da) |
PL (1) | PL360285A1 (da) |
WO (1) | WO2001094325A1 (da) |
ZA (1) | ZA200209769B (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003040115A1 (fr) * | 2001-11-09 | 2003-05-15 | Aventis Pharma S.A. | Derives de 2-amino-thiazoline et leur utilisation comme inhibiteurs de no-synthase inductible |
DE60140964D1 (en) * | 2001-09-26 | 2010-02-11 | Yissum Res Dev Co | Sphingolipiden |
DK1446402T3 (da) * | 2001-11-09 | 2006-03-06 | Aventis Pharma Sa | 2-Amino-4-heteroarylethylthiazolinderivater og deres anvendelse som inhibitorer for inducerbar NO-synthase |
IL161843A0 (en) * | 2001-11-09 | 2005-11-20 | Aventis Pharma Sa | Use of 2-amino-4-pyridylmethyl-thiazoline dervatives as inhibitors of inducible no-synthase |
AU2002238889A1 (en) * | 2002-03-14 | 2003-09-22 | Dainippon Pharmaceutical Co., Ltd. | Nitrogen monoxide synthase inhibitors |
ATE375333T1 (de) | 2002-08-07 | 2007-10-15 | Neuraxon Inc | Aminobenzothiazolverbindungen mit nos-hemmender wirkung |
DE10332560B4 (de) * | 2003-07-11 | 2010-07-08 | Chiracon Gmbh | Verfahren zur Herstellung von ß- Heteroaryl-2-alanin-Verbindungen über 2-Amino-2-(heteroarylmethyl)-carbonsäure-Verbindungen |
KR101800507B1 (ko) | 2015-09-18 | 2018-01-18 | 주식회사 이엔이티아이 | 자동세척 스크린과 식물정화장치를 활용하여 지속적으로 유입되는 생활하수나 공정폐수가 유입되는 오염하천정화를 위한 방법 및 그 장치 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5066662A (en) * | 1990-05-21 | 1991-11-19 | Warner-Lambert Company | Substituted oxazolidin-2-ones and 1,2,4-oxadiazolin-5-ones and derivatives thereof acting at muscarinic receptors |
JPH08503940A (ja) * | 1992-11-27 | 1996-04-30 | ザ ウエルカム ファウンデーション リミテッド | 酵素阻害薬 |
ATE177078T1 (de) * | 1993-10-21 | 1999-03-15 | Searle & Co | Amidino-derivate als no-synthetase inhibitoren |
AU4149696A (en) * | 1994-11-15 | 1996-06-06 | Merck & Co., Inc. | Substituted heterocycles as inhibitors of nitric oxide synthase |
ES2238335T3 (es) * | 1999-12-24 | 2005-09-01 | Kyowa Hakko Kogyo Co., Ltd. | Derivados de purina condensados. |
-
2000
- 2000-06-09 FR FR0007397A patent/FR2810037B1/fr not_active Expired - Fee Related
-
2001
- 2001-06-07 IL IL15332801A patent/IL153328A0/xx unknown
- 2001-06-07 JP JP2002501875A patent/JP4238026B2/ja not_active Expired - Fee Related
- 2001-06-07 AT AT01943580T patent/ATE305460T1/de not_active IP Right Cessation
- 2001-06-07 DZ DZ013367A patent/DZ3367A1/xx active
- 2001-06-07 OA OA1200200372A patent/OA12286A/fr unknown
- 2001-06-07 EP EP01943580A patent/EP1299365B1/fr not_active Expired - Lifetime
- 2001-06-07 MX MXPA02012071A patent/MXPA02012071A/es active IP Right Grant
- 2001-06-07 WO PCT/FR2001/001760 patent/WO2001094325A1/fr active IP Right Grant
- 2001-06-07 CA CA002411760A patent/CA2411760C/fr not_active Expired - Fee Related
- 2001-06-07 PL PL36028501A patent/PL360285A1/xx unknown
- 2001-06-07 ES ES01943580T patent/ES2248347T3/es not_active Expired - Lifetime
- 2001-06-07 KR KR1020027016766A patent/KR20030025931A/ko not_active Application Discontinuation
- 2001-06-07 AU AU2001266124A patent/AU2001266124A1/en not_active Abandoned
- 2001-06-07 DK DK01943580T patent/DK1299365T3/da active
- 2001-06-07 BR BR0111986-9A patent/BR0111986A/pt not_active Application Discontinuation
- 2001-06-07 NZ NZ522968A patent/NZ522968A/en unknown
- 2001-06-07 AR ARP010102730A patent/AR029937A1/es not_active Application Discontinuation
- 2001-06-07 EA EA200300010A patent/EA200300010A1/ru unknown
- 2001-06-07 AP APAP/P/2002/002708A patent/AP2002002708A0/en unknown
- 2001-06-07 DE DE60113689T patent/DE60113689T2/de not_active Expired - Lifetime
- 2001-06-07 CN CNB01813386XA patent/CN1202096C/zh not_active Expired - Fee Related
- 2001-06-07 HU HU0301000A patent/HUP0301000A2/hu unknown
-
2002
- 2002-12-02 ZA ZA200209769A patent/ZA200209769B/en unknown
- 2002-12-06 HR HR20020970A patent/HRP20020970A2/xx not_active Application Discontinuation
- 2002-12-06 NO NO20025884A patent/NO20025884L/no not_active Application Discontinuation
- 2002-12-09 MA MA26939A patent/MA25814A1/fr unknown
- 2002-12-09 EC EC2002004375A patent/ECSP024375A/es unknown
-
2004
- 2004-02-06 HK HK04100771A patent/HK1057900A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1572200B1 (fr) | Derives d'aminoindazoles et leur utilisation comme inhibiteurs de kinases | |
EP1675836B1 (fr) | Derives du 4-phenylthiazole et leur utilisation comme medicaments pour le traitement de maladies neurodegeneratives, la douleur et l'epilepsie | |
FR2847253A1 (fr) | Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant | |
US7662842B2 (en) | Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents | |
EP1446393B1 (fr) | Derives de 2-amino-thiazoline et leur utilisation comme inhibiteurs de no-synthase inductible | |
CA2465691C (fr) | Derives de 2-amino-4-heteroarylethyl thiazoline et leur utilisation comme inhibiteurs de no-synthase inductible | |
OA12286A (en) | 2-Aminothiazoline derivatives and their use as no-synthase inhibitors. | |
CA2465877C (fr) | Utilisation de derives de 2-amino-4-pyridylmethyl-thiazoline comme inhibiteurs de non-synthase inductible | |
EP0375510A1 (fr) | Dérivés d'imino-2 polyfluoroalcoxy-6 benzothiazole, leurs procédés de préparation et les médicaments les contenant | |
FR2915747A1 (fr) | Derives de tri-amino-pyrimidine comme inhibiteurs de phosphatase cdc25 | |
US6699895B2 (en) | 2-aminothiazoline derivatives and process for preparing the same | |
CA2411572C (fr) | Derives de 4,5-dihydro-thiazol-2-ylamine et leur utilisation comme inhibiteurs de no synthase | |
FR2832152A1 (fr) | Utilisation de derives de 2-amino-thiazoline comme inhibiteurs de no-synthase inductible | |
FR2832150A1 (fr) | Utilisation de derives de 2-amino-4-pyridylmethyl-thiazoline comme inhibiteurs de no-synthase inductible | |
FR2832151A1 (fr) | Utilisation de derives de 2-amino-4-heteroarylethyl-thiazoline comme inhibiteurs de no-synthase inductible | |
FR2710062A1 (fr) | Dérivés d'acide 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxyde-3-carboxylique, leur préparation et les médicaments les contenant. | |
FR2855520A1 (fr) | Nouveaux derives d'imidazoles, leur preparation et leur utilisation en tant que medicament |